Lighthouse Global Group Increases Immigration Consulting Service
HONG KONG SAR - Media OutReach - 4 June 2021 - In recent years, there…
5 years ago
Prime Day 2021: Two Days of Epic Savings Starting June 21 with More than 2 Million Deals Globally
Prime Day 2021 returns to Singapore on June 21 and 22 and will feature more…
5 years ago
Clinical Trial Results of the BCMA CAR-T Co-developed by IASO Biotherapeutics and Innovent Commented in American Society of Hematology’s Medical Journal, Blood
PLEASANTON, Calif. & NANJING, China--(BUSINESS WIRE)--#EHA2021--IASO Biotherapeutics (IASO Bio) and Innovent Biologics, Inc. (Innovent, HKEX:…
5 years ago
Snowplus Experiences Global Growth Despite COVID
The leading vape brand found success through partnerships and localized strategies. HONG KONG--(BUSINESS WIRE)--Snowplus, a…
5 years ago
AHF: US COVID Vaccine Donation – ‘Too Little Too Late!’
WASHINGTON--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) today sharply criticized the Biden Administration on its announcement today…
5 years ago
Ben Wyatt to join Rio Tinto Board
MELBOURNE, Australia--(BUSINESS WIRE)--Rio Tinto has appointed Ben Wyatt as a non-executive director. Mr Wyatt, an…
5 years ago
Procter & Gamble in Partnership with the Tokyo 2020 Organizing Committee and the International Olympics Committee Unveils Olympic and Paralympic Games Tokyo 2020 Medal Ceremony Podiums Made of Recycled Plastic
--(BUSINESS WIRE)--Multimedia is available on Business Wire's website and the Associated Press photo network of…
5 years ago
Invivoscribe Premieres 12-Color Flow Cytometry Capabilities at their Reference Labs in the US, Europe, and China
SAN DIEGO--(BUSINESS WIRE)--#invivoscribe--Today Invivoscribe, a global leader in precision diagnostics, announced the launch of a…
5 years ago
Internet Has 363.5 Million Domain Name Registrations at the End of the First Quarter of 2021
RESTON, Va.--(BUSINESS WIRE)--VeriSign, Inc. (NASDAQ: VRSN), a global provider of domain name registry services and…
5 years ago
CORRECTING and REPLACING IASO Receives NMPA Acceptance of its First Indication IND Application for CT120, a Fully Human CD19/CD22 Dual-Targeting CAR-T Therapy
PLEASANTON, Calif. & NANJING, China--(BUSINESS WIRE)--#Biopharmaceutical--First sentence of release should read: "...has been accepted by…
5 years ago